|
2023
|
Invention
|
Pharmaceutical composition comprising dapagliflozin base in amorphous form. The present invention... |
|
|
Invention
|
Stable pharmaceutical composition with improved genotoxic impurity profile. The present invention... |
|
|
Invention
|
Multi-layer pharmaceutical formulation of mirabegron and solifenacin succinate. The present inven... |
|
|
Invention
|
Empagliflozin composition with independent dissolution profile. The present invention relates to ... |
|
|
Invention
|
Fixed-dose combination formulations with low level of impurity profile. The present invention rel... |
|
|
Invention
|
Modified release mirabegron formulations. The present invention relates to prolonged-release tabl... |
|
|
Invention
|
Low dose riociguat compositions. The present invention relates to a pharmaceutical composition co... |
|
|
Invention
|
Pharmaceutical compositions of riociguat. The present invention provides an immediate-release ora... |
|
|
Invention
|
Pharmaceutical compositions comprising vortioxetine hydrobromide with improved nitrosamine impuri... |
|
2022
|
Invention
|
Stable pharmaceutical composition comprising linagliptin. The present invention relates to a stab... |
|
|
Invention
|
Stable pharmaceutical compositions comprising amorphous tolvaptan. The present invention relates ... |
|
|
Invention
|
Homogenously splittable tablet compositions comprising carglumic acid. The present invention rela... |
|
|
Invention
|
Pharmaceutical compositions of mirabegron. The present invention relates to a homogenous pharmace... |
|
|
Invention
|
Monolayer tablet composition of empagliflozin and metformin hydrochloride. The present invention ... |
|
|
Invention
|
Bilayer tablet composition with biphasic delivery system. The present invention relates to a bila... |
|
|
Invention
|
Pharmaceutical composition comprising propiverine hydrochlorde in matrix form. The present invent... |
|
|
Invention
|
Bioequivalent oral pharmaceutical composition comprising duloxetine hydrochloride. The present in... |
|
|
Invention
|
Immediate release oral pharmaceutical composition comprising linagliptin. The present invention r... |
|
2021
|
Invention
|
Pharmaceutical composition comprising amorphous tolvaptan. The present invention relates to a pha... |
|
|
Invention
|
Release of propiverine compositions in gastric conditions. The present invention relates to pharm... |
|
|
Invention
|
Improved manufacturing method for formulations comprising amorphous tolvaptan. The present invent... |
|
|
Invention
|
Pharmaceutical composition comprising mirabegron in matrix form. The present invention relates to... |
|
|
Invention
|
Lurasidone hydrochloride compositions. The present invention relates to a pharmaceutical composit... |
|
|
Invention
|
Pharmaceutical composition comprising mirabegron and calcium salts. The present invention relates... |
|
|
Invention
|
Enteric coated pharmaceutical composition of propiverine hydrochloride. The present invention rel... |
|
|
Invention
|
Pharmaceutical composition comprising vortioxetine hydrobromide in crystalline form sf. in vivoin... |
|
2020
|
Invention
|
Stable bilayer tablet compositions. The present invention relates to a bilayer tablet composition... |
|
|
Invention
|
Homogenous compositions of propiverine hci formulations. The present invention relates to a homog... |
|
|
Invention
|
Stable sustained release compositions of acemetacine. The present invention relates to a stable s... |
|
|
Invention
|
High drug load compositions of favipiravir. The present invention relates to high drug load oral ... |
|
|
Invention
|
Prolonged release mirabegron formulations. The present invention relates to a prolonged release f... |
|
|
Invention
|
Direct compression method for non-micronised apixaban formulations. The present invention relates... |
|
|
Invention
|
Multi-layered tablet formulation with extended release layer of metformin hydrochloride. The pres... |
|
|
Invention
|
Immediate release composition of favipiravir. The present invention relates to immediate release ... |
|
|
Invention
|
Sustained release formulation compositions comprising propiverine. The present invention relates ... |
|
|
Invention
|
Improved wet granulation processes for apixaban comprising formulations. The present invention re... |
|
|
Invention
|
Enteric coated duloxetine compositions. The present invention relates to an enteric coated pellet... |
|
|
Invention
|
Improved manufacturing method for the formulations comprising vortioxetine hbr butanol solvate fo... |
|
2019
|
Invention
|
A solid oral pharmaceutical gemifloxacin mesylate composition with improved release pattern and d... |
|
|
Invention
|
Gastro-resistant pellet comprising duloxetine. The present invention relates to a gastro-resistan... |
|
|
Invention
|
An enteric coated pellet comprising duloxetine hydrochloride with optimized degrees of neutraliza... |
|
|
Invention
|
Oral solid pharmaceutical compositions comprising lanthanum carbonate octahydrate. The subject in... |
|
|
Invention
|
Pharmaceutical compositions comprising ticagrelor. The present invention relates to a pharmaceuti... |
|
|
Invention
|
Solid pharmaceutical formulations comprising ticagrelor. The present invention relates to a pharm... |
|
|
Invention
|
Oral formulations comprising sitagliptin hci monohydrate with improved pharmaceutical characteris... |
|
|
Invention
|
A unique granulation process for rivaroxaban containing granules. An oral pharmaceutical formulat... |
|
2018
|
Invention
|
Oral formulations comprising rivaroxaban. The present invention relates to an immediate release s... |
|
|
Invention
|
Sustained release acemetacin compositions. The invention relates to the sustained release pharmac... |
|
|
Invention
|
Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof. The invention re... |
|
|
Invention
|
Controlled release propiverine formulations. The present invention relates to controlled release ... |
